Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 10, 2010, Pages 1244-1251

  Thomas, T A ^a,b,c   Shenoi, S V ^a,b   Heysell, S K ^a,b,c   Eksteen, F J ^a,d   Sunkari, V B ^e   Gandhi, N R ^a,f   Friedland, G ^a,b   Shah, N Sarita ^a,f  

^a Tugela Ferry Care and Research Collaboration   (South Africa)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Church of Scotland Hospital   (South Africa)

^e King George V Hospital Durban   (South Africa)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Co infection; Drug resistant tuberculosis; Extensively drug resistant tuberculosis; HIV TB; Pediatrics; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; EFAVIRENZ; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LAMIVUDINE; MOXIFLOXACIN; NEVIRAPINE; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; STREPTOMYCIN; TERIZIDONE;

ACUTE PSYCHOSIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERACTIVITY; MALE; MENTAL INSTABILITY; MIXED INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL POPULATION; SCHOOL CHILD; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CHILD; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RURAL POPULATION; SOUTH AFRICA; SPUTUM; TREATMENT OUTCOME;

EID: 77957096791     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. World Health Organization. Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009.426. Geneva, Switzerland: WHO, 2009.
2. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/TB/2006.371. Geneva, Switzerland: WHO, 2006.
3. Donald P R. Childhood tuberculosis: out of control? Curr Opin Pulm Med 2002; 8: 178-182.
4. Lawn S D, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009; 4: 325-333.
5. Shenoi S, Heysell S, Moll A, Friedland G. Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community. Curr Opin Infect Dis 2009; 22: 11-17.
6. Schaaf H, Gie R, Beyers N, Sirgel F, de Klerk P, Donald P. Primary drug-resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149-1155.
7. Schaaf H S, Marais B J, Hesseling A C, Brittle W, Donald P R. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009; 99: 1486-1490.
8. Schaaf H, Willemse M, Donald P. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis. Pediatr Infect Dis J 2009; 28: 748-750.
9. Condos R, Hadgiangelis N, Leibert E, Jacquette G, Harkin T, Rom W. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis. Chest 2008; 134: 187-192.
10. Keshavjee S, Gelmanova I Y, Farmer P E, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372: 1403-1409.
11. Mitnick C, Shin S, Seung K, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-574.
12. Migliori G B, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623-626.
13. Shah N S, Pratt R, Armstrong L, Robison V, Castro K G, Cegielski J P. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA 2008; 300: 2153-2160.
14. Kwon Y S, Kim Y H, Suh G Y, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008; 47: 496-502.
15. Gandhi N R, Shah N S, Andrews J R, et al. HIV co-infection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010; 181: 80-86.
16. World Health Organization. Global tuberculosis control: epidemiology, planning, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
17. Gandhi N, Moll A, Sturm A, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580. (Pubitemid 44780738)
18. Andrews J, Gandhi N, Moodley P, et al. Exogenous re-infection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis 2008; 198: 1582-1589.
19. Reves R, Blakey D, Snider D J, Farer L. Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. Am J Epidemiol 1981; 113: 423-435. (Pubitemid 11156561)
20. Ridzon R, Kent J, Valway S, et al. Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California. J Pediatr 1997; 131: 863-868.
21. Schaaf H S, Van Rie A, Gie R P, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J 2000; 19: 695-699.
22. Nivin B, Nicholas P, Gayer M, Frieden T, Fujiwara P. A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis 1998; 26: 303-307. (Pubitemid 28083938)
23. Institute Superiore di Sanita, Cooperazione Italiana. Tuberculosis MDR/XDR: the Msinga experience. Lessons learnt from South Africa, 2005-2009. Pietermaritzburg, KwaZulu-Natal, South Africa: ISS & Cooperazione Italiana, in partnership with Umzinyathi District Management, 2009.
24. Parsons S A, Abbott G. TB risk assessment report: Church of Scotland Hospital. Pretoria, South Africa: COSH, 2009.
25. Department of Health, South Africa. The South African National Tuberculosis Control Programme practical guidelines, 2004. Pretoria, South Africa: DoH, 2004.
26. Mitchison D. Drug resistance in tuberculosis. Eur Respir J 2005; 25: 376-379.
27. Stop TB Department, World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2008.402. Geneva, Switzerland: WHO, 2008.
28. McIlleron H, Willemse M, Werely C J, et al. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis 2009; 48: 1547-1553.
29. Shenoi S, Gandhi N R, Moll A P, et al. Clinical characteristics of survivors of XDR-TB and HIV co-infection in rural KwaZulu-Natal, South Africa. Cape Town, South Africa: International AIDS Society, 2009.
30. Zar H, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365: 130-134. (Pubitemid 40091802)
31. Schaaf H. Drug-resistant tuberculosis in children. S Afr Med J 2007; 97: 995-997.
32. Starke J R. Transmission of Mycobacterium tuberculosis to and from children and adolescents. Sem Pediatr Infect Dis 2001; 12: 115-123.
33. Weinstein J, Barrett C, Baltimore R, Hierholzer W J. Nosocomial transmission of tuberculosis from a hospital visitor on a pediatrics ward. Pediatr Infect Dis J 1995; 14: 232-234.
34. Aznar J, Safi H, Romero J, Alejo A, Gracia A, Palomares J. Nosocomial transmission of tuberculosis infection in pediatrics wards. Pediatr Infect Dis J 1995; 14: 44-48.
35. Basu S, Andrews J, Poolman E, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 2007; 370: 1500-1507. (Pubitemid 47628865)
36. World Health Organization, Stop TB Department & Department of Child and Adolescent Health and Development. Ethambutol efficacy and toxicity: literature review and recommendations for daily and intermittent dosage in children. WHO/HTM/TB/2006.365. Geneva, Switzerland: WHO, 2006.